Psoriatic Arthritis and Spondyloarthritis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

STUDY VISITS

0 +

PATIENTS

RHEUMATOLOGISTS

Participating Sites

CorEvitas has psoriatic arthritis and spondyloarthritis clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.

Outcome measures in the CorEvitas Psoriatic Arthritis and Spondyloarthritis Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Clinician Reported Outcomes

Calculated Outcomes

American College of Rheumatology Response Criteria (ACR)
Disease Activity Score (DAS)
Clinical Disease Activity Index (CDAI)
Simple Disease Activity Index (SDAI)
Psoriatic Arthritis Response Criteria (PsARC)
Psoriatic Arthritis Disease Activity Score (PASDAS)
Composite Psoriatic Disease Activity Index (CPDAI)
Assessment of Spondyloarthritis International Society (ASAS) scores
Ankylosing Spondylitis Disease Activity Score (ASDAS)

Patient Reported Outcomes

Work Productivity and Activity Impairment (WPAI)
Euro-QoL Group EQ-5D-5L
Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S)
Patient Visual Analogue Scale
Stiffness Visual Analogue Scale
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Bath Ankylosing Spondylitis Functional Index (BASFI)
Assessment of Spondyloarthritis International Society Health Index (ASAS HI)

Registry Scientific Advisors

Philip J. Mease, MD

Clinical Professor, University of Washington School of Medicine | Director of Rheumatology Research, Swedish Medical Center, Seattle, WA | Clinician, Seattle Rheumatology Associates

Alexis R. Ogdie-Beatty, MD, MSCE

Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania | Associate Professor of Epidemiology, University of Pennsylvania | Clinician, Penn Medicine

Subscribe to our newsletter